16 Einträge gefunden

1. Ovarian Cancer-Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial

   1. Schouten, Philip C
   2. Richters, Lisa
   3. Vis, Daniel J
   4. Kommoss, Stefan
   5. van Dijk, Ewald
   6. Ernst, Corinna
   7. Kluin, Roelof J C

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial

   1. Jank, Paul
   2. Gehlhaar, Claire
   3. Lederer, Bianca
   4. Fontanella, Caterina
   5. Schneeweiss, Andreas
   6. Karn, Thomas
   7. Marmé, Frederik

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status

   1. Jurmeister, Philipp
   2. Weber, Karsten
   3. Villegas, Sonia
   4. Karn, Thomas
   5. Untch, Michael
   6. Thieme, Anne
   7. Müller, Volkmar

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials

   1. Furlanetto, Jenny
   2. Marmé, Frederik
   3. Seiler, Sabine
   4. Thode, Christian
   5. Untch, Michael
   6. Schmatloch, Sabine
   7. Schneeweiss, Andreas

   2021 - Forschungsinformationssystem des UKE
5. Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

   1. Sinn, Bruno V
   2. Loibl, Sibylle
   3. Hanusch, Claus A
   4. Zahm, Dirk-Michael
   5. Sinn, Hans-Peter
   6. Untch, Michael
   7. Weber, Karsten

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer:Data From the GeparOcto-GBG 84 Trial

   1. Rüger, Alexandra Maria
   2. Schneeweiss, Andreas
   3. Seiler, Sabine
   4. Tesch, Hans
   5. van Mackelenbergh, Marion
   6. Marmé, Frederik
   7. Lübbe, Kristina

   2020 - Forschungsinformationssystem des UKE
7. A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

   1. Karn, Thomas
   2. Meissner, Tobias
   3. Weber, Karsten E
   4. Solbach, Christine
   5. Denkert, Carsten
   6. Engels, Knut
   7. Fasching, Peter A

   2020 - Forschungsinformationssystem des UKE
8. MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial

   1. Jank, Paul
   2. Gehlhaar, Claire
   3. Bianca, Lederer
   4. Caterina, Fontanella
   5. Andreas, Schneeweiss
   6. Karn, Thomas
   7. Marmé, Frederik

   2020 - Forschungsinformationssystem des UKE
9. Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial

   1. Witzel, Isabell
   2. Loibl, Sibylle
   3. Wirtz, Ralph
   4. Fasching, Peter A
   5. Denkert, Carsten
   6. Weber, Karsten
   7. Lück, Hans-Joachim

   2019 - Forschungsinformationssystem des UKE
10. Deleterious somatic variants in 473 consecutive individuals with ovarian cancer:results of the observational AGO-TR1 study (NCT02222883)

    1. Hauke, Jan
    2. Hahnen, Eric
    3. Schneider, Stephanie
    4. Reuss, Alexander
    5. Richters, Lisa
    6. Kommoss, Stefan
    7. Heimbach, André

    2019 - Forschungsinformationssystem des UKE
11. Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor

    1. Loibl, Sibylle
    2. Weber, Karsten
    3. Huober, Jens
    4. Krappmann, Kristin
    5. Marmé, Frederik
    6. Schem, Christian
    7. Engels, Knut

    2018 - Forschungsinformationssystem des UKE
12. Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials

    1. van Mackelenbergh, Marion T
    2. Denkert, Carsten
    3. Nekljudova, Valentina
    4. Karn, Thomas
    5. Schem, Christian
    6. Marmé, Frederik
    7. Stickeler, Elmar

    2018 - Forschungsinformationssystem des UKE
13. Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

    1. Harter, Philipp
    2. Hauke, Jan
    3. Heitz, Florian
    4. Reuss, Alexander
    5. Kommoss, Stefan
    6. Marmé, Frederik
    7. Heimbach, André

    2017 - Forschungsinformationssystem des UKE - frei zugänglich
14. Plasma S100P level as a novel prognostic marker of metastatic breast cancer

    1. Peng, Cike
    2. Chen, Hongda
    3. Wallwiener, Markus
    4. Modugno, Caroline
    5. Cuk, Katarina
    6. Madhavan, Dharanija
    7. Trumpp, Andreas

    2016 - Forschungsinformationssystem des UKE
15. Plasma Hyaluronic Acid level as a Prognostic and Monitoring Marker of Metastatic Breast Cancer

    1. Peng, Cike
    2. Wallwiener, Markus
    3. Rudolph, Anja
    4. Ćuk, Katarina
    5. Eilber, Ursula
    6. Celik, Muhabbet
    7. Modugno, Caroline

    2016 - Forschungsinformationssystem des UKE
16. The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.

    1. Wallwiener, Markus
    2. Hartkopf, Andreas Daniel
    3. Baccelli, Irène
    4. Riethdorf, Sabine
    5. Schott, Sarah
    6. Pantel, Klaus
    7. Marmé, Frederik

    2013 - Forschungsinformationssystem des UKE